April 2024: U.S. officials warn about botulism-like illness linked to counterfeit Botox
The FDA released images of the fake Botox causing illness and hospitalizations across the country.
According to officials in Illinois and Tennessee, six people developed a botulism-like illness and four of them were hospitalized after receiving cosmetic injections in what the CDC has characterized as “non-medical settings.” As of April 19, 2024 the investigation has expanded to 22 people in 11 states.
Patients presented with classic signs of botulism, which include blurry or double vision, droopy eyelids, difficulty breathing, fatigue, slurred speech and hoarse voice. The disease can progress to total paralysis, and can be fatal.
More Information:
- Counterfeit version of Botox found in multiple states, FDA, April 16, 2024 - identifies the counterfeit product, posting photos and a list of distinguishing features
- Harmful reactions linked to counterfeit “Botox” or mishandled Botulinum Toxin injections, CDC, April 15, 2024 - tracks the scope of the outbreak
PSM can provide media a quotable expert for your counterfeit Botox story. Reach us at editors@safemedicines.org and specify your story deadline.